| Income Statement | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-09-30 |
|---|---|---|---|---|
| Total other income (expense), net | -14,358 | -1,478 | 586 | 742 |
| Net loss | - | - | -13,265 | -14,020 |
| Net loss and comprehensive loss | -16,287 | -15,844 | -13,265 | -14,020 |
| Earnings per share, basic | -0.11 | -0.16 | -0.18 | -0.22 |
| Earnings per share, diluted | -0.11 | -0.16 | -0.18 | -0.22 |
| Weighted average number of shares outstanding, basic | 144,106,869 | 96,447,672 | 74,700,364 | 63,465,063 |
Xilio Therapeutics, Inc. (XLO)
Xilio Therapeutics, Inc. (XLO)